What We Know About TMEM175 in Parkinson's Disease
CNS Neuroscience & Therapeutics · 2025-01 · 31 (1)
DOI: 10.1111/cns.70195 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 20.01.2025. Verfasst von Jing Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical Record Information Section, Yantai Yuhuangding Hospital, Yantai, Shandong, China. Hauptthemen laut MEDLINE: Parkinson Disease, Membrane Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shandong Provincial Natural Science Foundation, Shandong Provincial Hospital Research Incubation Fund, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Background
Lysosome is a highly heterogeneous membranous organelle in eukaryotic cells, which regulates many physiological processes in the cell. Studies have found that lysosomal dysfunction disrupts cellular homeostasis and is associated with Parkinson's disease (PD). Transmembrane protein 175 (TMEM175) is a lysosomal cation channel whose activity is essential for lysosomal homeostasis. At present, it has been confirmed that TMEM175 is related to the pathogenesis of PD, but the relationship between the two remains unclear.
Aims
A thorough comprehension of the structure and function of TMEM175 would greatly contribute to elucidating the achievement of this objective. In this paper, the structure, composition, and function of TMEM175 and its relationship with PD will be reviewed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Record Information Section, Yantai Yuhuangding Hospital, Yantai, Shandong, China.
- Department of Neurology, Jinan Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
- Department of Neurology, Xuanwu Jinan Hospital, Jinan, Shandong, China.
- Department of Neurology, Linyi People's Hospital, Linyi, Shandong, China.
- Department of Neurology, The Affiliated Hospital of Qingdao University, Qingdao, China.
- Department of Otolaryngology and Head and Neck, Chongqing General Hospital, Chongqing, China.
ORCID-Profile: Lingyan Zhou
Förderung
- Shandong Provincial Natural Science Foundation
- Shandong Provincial Hospital Research Incubation Fund
- Natural Science Foundation of Shandong Province
Zitieren
APA
Wang, J., Sun, X., Cheng, L., Qu, M., Zhang, C., Li, X., & Zhou, L. (2025). What We Know About TMEM175 in Parkinson's Disease. CNS Neuroscience & Therapeutics, 31(1). https://doi.org/10.1111/cns.70195
Vancouver
Wang J, Sun X, Cheng L, Qu M, Zhang C, Li X, et al. What We Know About TMEM175 in Parkinson's Disease. CNS Neuroscience & Therapeutics. 2025;31(1). doi:10.1111/cns.70195
BibTeX
@article{Wang2025,
author = {Wang, Jing and Sun, Xuechun and Cheng, Lufeng and Qu, Meijie and Zhang, Chanyuan and Li, Xueting and Zhou, Lingyan},
title = {What We Know About TMEM175 in Parkinson's Disease},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
volume = {31},
number = {1},
doi = {10.1111/cns.70195}
}
EUVIMED